AAAAAA

   
Results: 1-9 |
Results: 9
Antibiotic use in public hospitals in Taiwan after the implementation of National Health Insurance
Authors: Chang, SC Chen, YC Hu, OYP
Citation: Sc. Chang et al., Antibiotic use in public hospitals in Taiwan after the implementation of National Health Insurance, J FORMOS ME, 100(3), 2001, pp. 155-161
Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies
Authors: Yen, SY Sung, KC Wang, JJ Hu, OYP
Citation: Sy. Yen et al., Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies, INT J PHARM, 220(1-2), 2001, pp. 91-99
Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusion and iontophoresis
Authors: Fang, JY Sung, KC Hu, OYP Chen, HY
Citation: Jy. Fang et al., Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusion and iontophoresis, ARZNEI-FOR, 51(5), 2001, pp. 408-413
High-performance liquid chromatographic method for the simultaneous determination of nalbuphine and its prodrug, sebacoyl dinalbuphine ester, in dog plasma and application to pharmacokinetic studies in dogs
Authors: Pao, LH Hsiong, CH Hu, OYP Ho, ST
Citation: Lh. Pao et al., High-performance liquid chromatographic method for the simultaneous determination of nalbuphine and its prodrug, sebacoyl dinalbuphine ester, in dog plasma and application to pharmacokinetic studies in dogs, J CHROMAT B, 746(2), 2000, pp. 241-247
Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics ofangiotensin-converting enzyme inhibitors?
Authors: Ding, PYA Hu, OYP Pool, PE Liao, WC
Citation: Pya. Ding et al., Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics ofangiotensin-converting enzyme inhibitors?, J HUM HYPER, 14(3), 2000, pp. 163-170
Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis
Authors: Sung, KC Fang, JY Hu, OYP
Citation: Kc. Sung et al., Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis, J CONTR REL, 67(1), 2000, pp. 1-8
Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance
Authors: Han, RY Fang, JY Sung, KC Hu, OYP
Citation: Ry. Han et al., Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance, INT J PHARM, 177(2), 1999, pp. 201-209
Fosinopril: Pharmacokinetics and pharmacodynamics in Chinese subjects
Authors: Ding, PYA Chu, KM Hu, OYP Huang, GM Jeng, JJ Chang, A Delaney, CL MacAskill, M Yang, BC Jemal, M Smith, R Liao, WC
Citation: Pya. Ding et al., Fosinopril: Pharmacokinetics and pharmacodynamics in Chinese subjects, J CLIN PHAR, 39(2), 1999, pp. 155-160
Cardiovascular effect and simultaneous pharmacokinetic and pharmacodynamicmodeling of pimobendan in healthy normal subjects
Authors: Chu, KM Hu, OYP Shieh, SM
Citation: Km. Chu et al., Cardiovascular effect and simultaneous pharmacokinetic and pharmacodynamicmodeling of pimobendan in healthy normal subjects, DRUG META D, 27(6), 1999, pp. 701-709
Risultati: 1-9 |